A real-world implementation study of a TDM-guided dalbavancin model for bone and joint infections (101 Dalbatians)
{{output}}
Background: Dalbavancin is increasingly used off-label for chronic Gram-positive bone and joint infections (BJIs) requiring prolonged antimicrobial therapy, but optimal dosing strategies and the role of therapeutic drug monitorin... ...
